| RefSeqID |
Gene Symbol |
Disease/Trait |
|
|
APOH |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
CEP112 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
CDH4 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
CDH10 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
CDH9 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
SCUBE2 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
SLC25A28 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
CEP112 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
ELF5 |
β2-Glycoprotein I (β2-GPI) plasma levels |
|
|
GALM |
5-HTT brain serotonin transporter levels |
|
|
CYP19A1 |
AB1-42 |
|
|
TOMM40 |
AB1-42 |
|
|
TOMM40 |
AB1-42 |
|
|
TOMM40 |
AB1-42 |
|
|
CDKN2A |
Abdominal aortic aneurysm |
|
|
CDKN2A |
Abdominal aortic aneurysm |
|
|
LRP1 |
Abdominal aortic aneurysm |
|
|
DAB2IP |
Abdominal aortic aneurysm |
|
|
CDKN2A |
Abdominal aortic aneurysm |
|
|
CDKN2A |
Abdominal aortic aneurysm |
|
|
DAB2IP |
Abdominal aortic aneurysm |
|
|
CYP4F2 |
Acenocoumarol maintenance dosage |
|
|
CYP2C18 |
Acenocoumarol maintenance dosage |
|
|
CNTN4 |
Acenocoumarol maintenance dosage |
|
|
F11 |
Activated partial thromboplastin time |
|
|
F5 |
Activated partial thromboplastin time |
|
|
HRG |
Activated partial thromboplastin time |
|
|
F12 |
Activated partial thromboplastin time |
|
|
KNG1 |
Activated partial thromboplastin time |
|
|
GRK6 |
Activated partial thromboplastin time |
|
|
GRK6 |
Activated partial thromboplastin time |
|
|
KNG1 |
Activated partial thromboplastin time |
|
|
MXD3 |
Activated partial thromboplastin time |
|
|
SLC34A1 |
Activated partial thromboplastin time |
|
|
PRR7 |
Activated partial thromboplastin time |
|
|
ADIPOQ |
Activated partial thromboplastin time |
|
|
UIMC1 |
Activated partial thromboplastin time |
|
|
AHSG |
Activated partial thromboplastin time |
|
|
FGFR4 |
Activated partial thromboplastin time |
|
|
GRK6 |
Activated partial thromboplastin time |
|
|
SELP |
Activated partial thromboplastin time |
|
|
SLC34A1 |
Activated partial thromboplastin time |
|
|
DBN1 |
Activated partial thromboplastin time |
|
|
RGS14 |
Activated partial thromboplastin time |
|
|
C6orf10 |
Activated partial thromboplastin time |
|
|
LMAN2 |
Activated partial thromboplastin time |
|
|
PRELID1 |
Activated partial thromboplastin time |
|
|
FETUB |
Activated partial thromboplastin time |
|
|
SURF2 |
Activated partial thromboplastin time |
|
|
ABO |
Activated partial thromboplastin time |
|
|
NSD1 |
Activated partial thromboplastin time |
|
|
MXD3 |
Activated partial thromboplastin time |
|
|
SURF4 |
Activated partial thromboplastin time |
|
|
DBN1 |
Activated partial thromboplastin time |
|
|
ADAMTS13 |
Activated partial thromboplastin time |
|
|
AGBL1 |
Activated partial thromboplastin time |
|
|
NSD1 |
Activated partial thromboplastin time |
|
|
RFC4 |
Activated partial thromboplastin time |
|
|
DDC |
Acute lymphoblastic leukemia (childhood) |
|
|
RYR2 |
Acute lymphoblastic leukemia (childhood) |
|
|
PDE4B |
Acute lymphoblastic leukemia (childhood) |
|
|
PTPRJ |
Acute lymphoblastic leukemia (childhood) |
|
|
TP63 |
Acute lymphoblastic leukemia (childhood) |
|
|
TP63 |
Acute lymphoblastic leukemia (childhood) |
|
|
TBXAS1 |
Acute lymphoblastic leukemia (childhood) |
|
|
SLCO3A1 |
Acute lymphoblastic leukemia (childhood) |
|
|
PYGL |
Acute lymphoblastic leukemia (childhood) |
|
|
PARD3 |
Acute lymphoblastic leukemia (childhood) |
|
|
PARD3 |
Acute lymphoblastic leukemia (childhood) |
|
|
IKZF1 |
Acute lymphoblastic leukemia (childhood) |
|
|
DDC |
Acute lymphoblastic leukemia (childhood) |
|
|
CEBPE |
Acute lymphoblastic leukemia (childhood) |
|
|
PTPRJ |
Acute lymphoblastic leukemia (childhood) |
|
|
PYGL |
Acute lymphoblastic leukemia (childhood) |
|
|
RIT2 |
Acute lymphoblastic leukemia (childhood) |
|
|
ZNF230 |
Acute lymphoblastic leukemia (childhood) |
|
|
MAGI2 |
Acute lymphoblastic leukemia (childhood) |
|
|
SLCO3A1 |
Acute lymphoblastic leukemia (childhood) |
|
|
MYRIP |
Acute lymphoblastic leukemia (childhood) |
|
|
INTS10 |
Acute lymphoblastic leukemia (childhood) |
|
|
PARD3 |
Acute lymphoblastic leukemia (childhood) |
|
|
C12orf5 |
Acute lymphoblastic leukemia (childhood) |
|
|
TBXAS1 |
Acute lymphoblastic leukemia (childhood) |
|
|
ARID5B |
Acute lymphoblastic leukemia (childhood) |
|
|
KCNE4 |
Acute lymphoblastic leukemia (childhood) |
|
|
KCNMB2 |
Acute lymphoblastic leukemia (childhood) |
|
|
OR2C3 |
Acute lymphoblastic leukemia (childhood) |
|
|
NCK2 |
Addiction |
|
|
NCK2 |
Addiction |
|
|
PEPD |
Adiponectin levels |
|
|
KNG1 |
Adiponectin levels |
|
|
PDE3A |
Adiponectin levels |
|
|
KNG1 |
Adiponectin levels |
|
|
PAPD4 |
Adiponectin levels |
|
|
PEPD |
Adiponectin levels |
|
|
VEGFA |
Adiponectin levels |
|
|
ADIPOQ |
Adiponectin levels |
|
|
VEGFA |
Adiponectin levels |
|
|
CDH13 |
Adiponectin levels |
|
|
CDH13 |
Adiponectin levels |